Home Blog Page 2950

Saronic Unveils Echelon: A Unified Platform for Mission Planning, Simulation, and Command-and-Control of Autonomous Surface Vessels

AUSTIN, Texas, July 30, 2025 /PRNewswire/ — Saronic Technologies today unveiled Echelon, a unified platform that enables advanced mission planning, high-fidelity simulation, and real-time command-and-control (C2) for its growing fleet of Autonomous Surface Vessels (ASVs). Built to enable scalable, distributed operations, Echelon allows a single operator to plan, simulate, and execute complex missions across multiple autonomous assets—using a single interface.

As maritime environments grow increasingly complex, Saronic introduces Echelon—a groundbreaking unified platform for high-fidelity simulation, advanced mission planning, and real-time C2 across its expanding fleet of Autonomous Surface Vessels (ASVs). (PRNewsFoto/Saronic)
As maritime environments grow increasingly complex, Saronic introduces Echelon—a groundbreaking unified platform for high-fidelity simulation, advanced mission planning, and real-time C2 across its expanding fleet of Autonomous Surface Vessels (ASVs). (PRNewsFoto/Saronic)

As maritime environments become increasingly contested and operationally complex, both defense and commercial users require intuitive solutions to deploy, manage, and dynamically task autonomous systems at scale. Success in these domains hinges on advanced mission planning, scalable C2, and the ability to operate reliably with or without continuous connectivity. Echelon aims to deliver on this need by combining mission planning, simulation, and execution capabilities into one system, accelerating deployment timelines and reducing cognitive load for operators.

With Echelon, operators are provided with an intuitive interface for rapidly designing and testing missions in a high-fidelity simulation environment. Enabled by Saronic’s deep instrumentation across the hardware and software stack, this simulation layer delivers full visibility into vessel autonomy, providing insight into the vessel’s performance capabilities prior to deployment. Once validated in simulation, the mission is easily deployed to the designated ASV(s). Mission observation and real-time control are available as needed, though Saronic ASVs are uniquely capable of operating independently without persistent communications, a critical requirement for denied or degraded environments.

During operation, Echelon prioritizes the safety, reliability, and effective control of Saronic ASVs. The platform combines ultra-low-latency video streaming with intelligent, autonomy-aware alerts generated from the vessels’ onboard sensors and mission telemetry. By surfacing only the most relevant data, from subsystem telemetry to autonomy behaviors, Echelon helps operators stay focused, informed, and ready to make high-impact decisions in real-time.

“Echelon is aligned with Saronic’s core belief that a vertically integrated system across both software and hardware will best enable our end users to achieve their mission objectives,” said Vibhav Altekar, Co-Founder and CTO at Saronic. “While our vessels remain compatible with third-party C2 systems, Echelon was purpose-built to unlock the full potential of Saronic’s autonomy stack and deliver an intuitive mission-ready capability to our customers.”  

Saronic continues to push the boundaries of distributed autonomy with Echelon. The unified platform represents a critical step forward in Saronic’s mission to enable one-to-many operations, where a single operator can command and control a heterogeneous fleet of ASVs—reliably, safely, and at scale.

For more information about Saronic, please visit: https://www.saronic.com.

Contact: Press@saronic.com

GLOBAL ARTIST OYORAM UNVEILS “TIMEPIECE” — A DYNAMIC 3D LED INSTALLATION IN DOWNTOWN DES MOINES

GREATER DES MOINES, Iowa, July 30, 2025 /PRNewswire/ — Time is taking on a new form in Downtown Des Moines (DSM). “TimePiece” is an innovative 3D LED installation that displays real time by world-renowned artist Yorame Mevorach (known professionally as Oyoram). The piece creates the illusion of depth and movement, transforming a flat surface into an immersive experience.

At the top of each hour, a digital mechanical arm springs to life in a captivating visual event, removing and replacing a clock face in a mesmerizing display. Blending art and technology, “TimePiece” becomes a vibrant, ever-changing centerpiece. The installation is located on The Fitch Building, facing the Pappajohn Sculpture Park.

“With TimePiece, I wanted to take the traditional element of telling time and reimagine it as a moment of visual surprise. Using light, movement and depth, the work becomes part of the city’s rhythm,” said Oyoram. “It’s not just about what you see, but how it makes you feel in the moment.”

“This is more than a public art piece, it’s a reflection of the creative energy that defines our region,” said Renae Mauk, Vice President of Downtown Development of the Greater Des Moines Partnership. “Partnering with an artist whose work spans the globe inspires new possibilities for public art in DSM. Oyoram brings international perspective with a deep commitment to Downtown DSM and Greater Des Moines community.”

The artist and filmmaker behind this visionary project, Oyoram, is based in Des Moines’ Historic Sherman Hill neighborhood and maintains a working studio in Paris. With the addition of a gallery for immersive art installations under construction, he hopes to create a bridge between visual artists in the two cities. Known for replacing conventional media screens with sculptural, immersive visuals, his work has been commissioned by global brands including Cartier, Van Cleef & Arpels, Sony, Louis Vuitton and Dior. Since 2007, he has created monumental moving images known as “Moving Fresques” and “Moving Fresco.” Recent international projects include installations for Cheval Blanc Spa in Paris and Tiffany & Co.’s Landmark store in New York City. Locally, his work includes Mental Banquet: Painting with Lights (2018), 7even Stories High: Immersive Elevator (2022), and the visual design for the Des Moines Metro Opera’s Bluebeard’s Castle (2023).

“Bringing this piece to fruition has been a journey marked by years of planning and meaningful financial investment, reflecting our unwavering belief in the power of art. TimePiece brings fresh, imaginative energy to our streetscape,” Angie Pfannkuch, Operation Downtown Board Chair. “Operation Downtown knows that investing in projects like TimePiece helps to elevate the identity and vision for what is possible when creativity is prioritized in public spaces.”

“Prairie Meadows is proud to invest in projects that strengthen and beautify our communities,” said Julie Stewart, Senior Vice President of Business Development at Prairie Meadows. “Public art is a powerful example of visionary investment that enhances quality of life, connects people to places and leaves a lasting impact. TimePiece is a dynamic addition that reflects the creativity and ambition of Downtown DSM.”

In alignment with the Downtown DSM: Future Forward Vision Plan and Action Plan, TimePiece exemplifies a commitment to inclusive, innovative art that resonates both locally and globally, strengthening the region. The installation was made possible by Operation Downtown, Prairie Meadows, Bravo Greater Des Moines, MidAmerican Energy Foundation, Downtown DSM, Inc., the Greater Des Moines Partnership and private donors, as well as in-kind contributions from Substance Architecture, Christensen Development and artist Oyoram.

See images of “TimePiece” here.

About Operation Downtown
Created to help make Downtown Des Moines (DSM) a safer, cleaner place to work, live and visit, Operation Downtown is classified as a Self-Supported Municipal Improvement District (SSMID). The mission is keeping Downtown DSM safe, clean, welcoming and vibrant, in support of a positive experience. Programs include trash cleanup, flower planting and visitor assistance. Operation Downtown, a 501(c)6, was formed in 1998 by business leaders to provide enhanced services that are not provided by the City of Des Moines. Today, the Greater Des Moines Partnership and Operation Downtown help to keep DSM among the highest-rated, most vibrant regions in the country. Learn more at operationdowntown.com.

About the Greater Des Moines Partnership
The Greater Des Moines Partnership is the economic and community development organization that serves 12 counties in Greater Des Moines (DSM), Iowa: Adair, Clarke, Dallas, Guthrie, Jasper, Madison, Mahaska, Marion, Marshall, Polk, Poweshiek and Warren. Together with more than 400 Investors and an Affiliate Chamber of Commerce network of more than 7,200 Regional Business Members, The Partnership drives economic growth and talent development to advance quality of life in DSM with one voice, one mission and as one region. Through innovation, strategic planning and global collaboration, The Partnership grows opportunity, helps create jobs and promotes DSM as the best place to build a business, a career and a future. Learn more at DSMpartnership.com.

Contact:
Kyle Oppenhuizen
koppenhuizen@DSMpartnership.com
(515) 286-4972
Learn More About DSM USA

 

Setouchi Triennale 2025: A Vital and Vibrant Festival of Art

SETOUCHI, Japan, July 30, 2025 /PRNewswire/ — The Setouchi Triennale is an essential celebration of contemporary art that unfolds across the islands of Japan’s stunning Seto Inland Sea. Since its inception in 2010, the festival has embraced the unifying theme of “Restoration of the Sea,” inviting artists, visitors, and locals to engage with the region’s natural beauty, history, and unlimited potential. Spanning 100 days and divided into spring, summer, and fall sessions, the Setouchi Triennale encourages exploration across the changing seasons and landscapes of Setouchi. Now in its sixth iteration, the festival has expanded its reach and appeal to 17 distinctive locations.

Benesse Art Site Naoshima
Benesse Art Site Naoshima

Kagawa Prefecture, and specifically the island of Naoshima, are central to the Setouchi Triennale and below are some highlights of what this spectacular area of Japan has to offer.

Hiroshi Sugimoto Gallery: Time Corridors

This gallery is dedicated to the work of artist Hiroshi Sugimoto. It offers an exceptional and immersive opportunity to engage with a broad spectrum of Sugimoto’s signature works including photographs, sculptures, and architectural projects all in one location, making it a singular destination on the world’s artistic stage. Sugimoto’s installation titled Time Corridors prompts reflection on memory, impermanence, and the meaning of life.

Benesse House Museum

Established in 1992 and designed by master architect Tadao Ando, Benesse House combines a museum and hotel in a striking coastal setting. In 2025, it unveiled a new exhibition featuring major Western artists including Frank Stella. With site-specific works and outdoor installations, it offers an immersive dialogue between art, architecture, and nature.

Liminal Air -core-

Rising eight meters at Takamatsu Port, Shinji Ohmaki’s mirrored, colorful sculpture shifts with light and movement, guiding visitors into a dynamic, immersive space. Blending reflection and perception, the work blurs boundaries between self and environment making this an engaging landmark for travelers and a powerful example of Ohmaki’s renowned, sensory-driven artistic practice.

The Kagawa Prefectural Arena

Opened in 2025, the Kagawa Prefectural Arena is a 10,000-capacity venue designed by globally acclaimed architectural firm SANAA. Its low, flowing form blends with the Seto Inland Sea landscape. On quieter days, public spaces invite casual visits, making it a gentle, architectural landmark that seamlessly connects daily life with art, nature, and large-scale events.

Setouchi Triennale 2025 Sessions
Spring:  April 18 – May 25
Summer: August 1 – August 31
Autumn: October 3 – November 9

CONTACT: https://www.setouchi.travel/en/

BON Launches AI-Powered New Drug Research and Development

XI’AN, China, July 30, 2025 /PRNewswire/ — Bon Natural Life Limited (Nasdaq: BON) (“BON” or “the Company”), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced the official launch of its AI-driven drug research and development (R&D) business. Leveraging its extensive library of natural compounds – many derived from Traditional Chinese Medicine (TCM) – the Company will apply artificial intelligence algorithms to identify high potential lead compounds, marking a significant evolution in its pharmaceutical strategy.

A lead compound is a molecule with specific biological activity and a chemical structure that serves as a foundation for further development in drug discovery. Identifying such compounds through activity screening is a fundamental step in early-stage pharmaceutical R&D.

With nearly two decades of experience in the research and development of natural products, BON has curated a robust library of biologically active compounds — many with proven therapeutic value and high druggability. While previous R&D efforts were limited by traditional screening technologies, the integration of advanced AI-driven models is expected to significantly enhance the efficiency, speed, and success rate of BON’s drug discovery process.

Yongwei Hu, BON’s CEO, stated, “Backed by the high druggability of our TCM-derived compound libraries and the efficiency of AI-powered screening technology, we are optimistic about Bon’s potential to achieve meaningful breakthroughs in drug discovery. This initiative represents a strategic leap forward for our company and reinforces our long-term commitment to innovation in pharmaceutical research.”

The Company’s new AI-driven platform is designed to quickly analyze and identify promising lead compounds for further optimization, supporting BON’s broader goals of accelerating the development of innovative therapies rooted in natural product chemistry.

About Bon Natural Life Limited (“BON”)

BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit http://www.bnlus.com.

Safe Harbor Statement

This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,””expects” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

NYSE Content Advisory: Pre-market update + Ambiq raises $96 million in IPO

NEW YORK, July 30, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

Kristen Scholer delivers the pre-market update on July 30th

  • Equities are little changed early Wednesday after a delayed trade deal with China took the S&P 500 three tenths of a percent from its record. It was the first session of the last seven that the index didn’t finish at an all-time high.
  • This afternoon, Americans will receive the Federal Reserve’s decision on interest rates. The market is nearly certain rates will remain unchanged despite pressure from the White House to lower them.
  • Chipmaker Ambiq debuts at the NYSE today after raising $96 million in its IPO. Shares priced at $24 in an upsized deal. Ambiq will trade under the ticker symbol AMBQ.

Opening Bell
Ambiq Micro (NYSE: AMBQ) celebrates its initial public offering

Closing Bell
Morgan Stanley (NYSE: MS) celebrates the launch of their new Power E*TRADE platform

Click here to download the NYSE TV App

 

Video – https://mma.prnasia.com/media2/2741064/NYSE_Market_Update_July_30.mp4 

Hesai’s JT Series 3D Lidar Revolutionizes the Future of Autonomous Farming

PALO ALTO, Calif., July 30, 2025 /PRNewswire/ — Hesai Technology (Nasdaq: HSAI), a global leader in lidar solutions, announces today that it will supply its advanced JT series lidar sensors to support the deployment of next-generation autonomous farming robots for Agtonomy and Alpha Werke. These partnerships bring together leading innovators in agricultural autonomy and robotics perception, accelerating the transformation of traditional farming to become smarter, more efficient, and more sustainable.

Lidar: The Eyes of AI “Farming Agents”

As a foundational sector of the global economy, farming sustains not only food systems but entire supply chains and communities—yet it now faces unprecedented challenges. Labor shortages are intensifying, operational costs are climbing, and climate unpredictability is making it harder than ever to ensure consistent yields. Farmers are under pressure to do more with less. The future of farming depends on physical AI—intelligent, connected autonomous farming robots that can work around the clock and adapt to complex environments.

At the heart of this transformation is lidar—a core sensing component that acts as the eyes of AI “farming agents”, enabling autonomous farming robots the spatial awareness they need to safely and accurately perform repetitive, labor-intensive tasks such as mowing, spraying, weeding, and hauling.

Hesai JT series mini hemispherical 3D lidar
Hesai JT series mini hemispherical 3D lidar

Hesai’s JT series—mini hemispherical 3D lidar sensors are designed with robotics applications in mind. They combine powerful environmental perception with a compact, robust design that’s ideal for autonomous farming.

  • Powerful perception: With an ultra-wide field of view covering the equivalent of two football fields, JT series sensors capture rich 3D data in real time. This enables AI systems to analyze crop loads, terrain, and surroundings with unmatched perception. The JT series also has a minimum detection range of 0 meters, enabling autonomous farming robots to perform close-range maneuvers with zero blind spots.
  • Compact size: Compared to similar products, the JT series is 70% smaller in volume. Its compact design allows for embedded installation on a wide range of autonomous farming robots, with a surface height of less than 30 mm. Whether it’s a ground-hugging weeding robot or a high-clearance spraying robot, JT series lidar can fit seamlessly.
  • Robust reliability: Because lidar actively emits laser light, it is not affected by ambient lighting conditions. This makes JT series lidar highly reliable across farming applications in challenging environments, at any time of day or night. JT sensors have also passed rigorous reliability tests—including IPX6 waterproofing, vibration and shock resistance, UV aging, and extreme temperature cycling—ensuring they stand up to the harshest farming environments.

What the Leaders Are Saying

Agtonomy, headquartered in California, is a leading agricultural technology company specializing in autonomous farming solutions. Agtonomy’s groundbreaking software for autonomous farming robots integrated with Hesai’s JT128 lidar enables farmers to easily monitor live progress, automate work, and manage fleets of vehicles.

“The seamless integration of Hesai’s lidar into Agtonomy-enabled tractors has significantly enhanced precision automation in agriculture. Hesai’s sensors provide reliable navigation, even in the most challenging conditions. Paired with our software, they allow us to automate numerous tasks—delivering an affordable and scalable solution for modern farms,” says Tim Bucher, CEO and Co-Founder, Agtonomy.

Alpha Werke, based in Austria, is an innovative agricultural robotics company focused on enabling autonomy in the most challenging off-road environments. Its flagship solution TracPilot is integrated with Hesai’s JT16 lidar, able to perceive complex terrain in real time and safely execute tasks like spraying and hauling in rugged conditions.

“Powered by Hesai’s lidar, we’re bringing autonomy to places GPS can’t reach—dense forests, orchards, and solar farms. Its reliability and precision makes Hesai an ideal partner for farming robots where safety, efficiency, and robust performance matter most,” says Patrick Neuhauser, CEO of Alpha Werke.

Empowering the Future of Farming, One Sensor at a Time

As the global agriculture industry faces increasing pressure such as labor shortages and rising costs, AI automation is poised to play a critical role. As of June 2025, Hesai has already delivered over 100,000 JT lidar units. Through its cutting-edge lidar sensors designed for autonomous farming robots, Hesai is committed to working hand-in-hand with agricultural innovators to enable the next revolution in autonomous farming, meeting the evolving demands of this multi-billion-dollar market.

 

CLO Unveils the zFab Kit: a Revolutionary AI-Powered Fabric Digitization System

NEW YORK, July 30, 2025 /PRNewswire/ — CLO Virtual Fashion, an industry leader in 3D garment visualization and design technology, announced the launch of the all-new CLO zFab Kit, a groundbreaking fabric digitization system set to transform the apparel and textile industries. The CLO zFab Kit, which includes three innovative devices—the zFab Cutter, the zFab Draper, and the zFab Scanner—will be available exclusively to CLO’s Enterprise clients. In conjunction with the company’s recent acquisition of swatchbook, the launch of the new zFab Kit places CLO as the world’s leading digital fabrics solutions provider.


Introducing: the all-new CLO zFab Kit, a revolutionary AI-powered fabric digitization system. Accurate, fast and seamlessly integrated into CLO. Pre-order today at zfabkit.clo3d.com

CLO’s new solution, powered by CLO’s state of the art AI technology, is designed to dramatically accelerate the fabric digitization process, enabling brands, vendors and suppliers – including accessory suppliers and fabric mills – to create accurate, high-quality digital representations of fabrics with unprecedented ease and precision. By integrating the zFab Kit into their workflow, CLO users can anticipate these benefits:

1. Superior Accuracy: The CLO zFab Kit dramatically cuts down errors during manual measurements. The system allows for streamlined cutting and analysis of the fabric’s physical qualities, ensuring digital versions in CLO are precise and reliable for use in design and production.

2. Enhanced Automation: Powered by CLO’s AI technology, the CLO zFab Kit automates the digitization process, significantly increasing speed, efficiency and accuracy for users.

3. Seamless Integration: The CLO zFab Kit is designed to work effortlessly with CLO’s existing suite of 3D design products and services, making it a breeze to work with high-quality digital fabric files within and beyond the CLO ecosystem.

“As the industry moves rapidly toward digital workflows powered by AI, fabric digitization is becoming essential to stay competitive. With our new CLO zFab Kit, we’re taking it to the next level” said Simon Kim, CEO at CLO Virtual Fashion. “Our unique approach – using our vast trove of fabric data amassed over many years computed via CLO’s AI technology – not only enhances the quality and accuracy of fabric representation, but also significantly reduces the time and resources needed compared to previous hardware and methods. Early adopters are already seeing faster sampling and stronger cross-team/industry collaboration. It also requires minimal setup and training times, and can scale across teams of any size with limited resources. We can’t wait to see how our users around the globe adopt and use the zFab kit to elevate their design processes.”

CLO’s Enterprise tier users can express their interest in the CLO zFab Kit and pre-order now by contacting their CLO representative in their respective regions. For more information about the CLO zFab Kit and to stay updated on the launch, visit zfabkit.clo3d.com.

About CLO Virtual Fashion:

CLO Virtual Fashion is the creator of CLO, the leading 3D fashion design software used and trusted by designers, small businesses, and titans of the fashion industry to achieve a seamless digital workflow. With over two decades of research and development in accurate garment simulation, CLO Virtual Fashion’s mission is to empower users at every step of the garment journey, from concept to design, fitting to manufacturing, from styling to marketing. In addition to 3D garment design software, CLO Virtual Fashion’s products include CLO-SET (a digital collaboration platform), CONNECT (a digital fashion hub and marketplace), and consumer-facing solutions such as e-commerce virtual fittings. CLO’s interconnected and ever-growing product ecosystem is built to power the future of everything related to garments.

CLO Unveils the zFab Kit: a Revolutionary AI-Powered Fabric Digitization System
CLO Unveils the zFab Kit: a Revolutionary AI-Powered Fabric Digitization System

Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company

– First global out-licensing deal since founding — tangible return on new drug development investments

– Significant milestone payments and future revenue expected — additional out-licensing of proprietary technologies anticipated

SEOUL, South Korea, July 30, 2025 /PRNewswire/ — Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment.

On July 30, DXVX announced that it has entered into a co-development and license agreement valued at approximately USD 220 million with a U.S.-based biotech company for its mRNA-based cancer vaccine. Revenue sharing post-commercialization will be handled separately.

Through this agreement, DXVX will grant its partner exclusive global rights to its patented mRNA-based cancer vaccine. The partner company will pay DXVX a total of approximately USD 220 million in development milestones and, following commercialization, sales-based milestone payments exceeding 10% of cumulative sales over a period of more than 15 years. Given the vast size and growth potential of the global oncology and cancer vaccine markets and the expected market share, DXVX projects that post-commercialization sales milestone revenues could exceed USD 940 million.

Even after the out-licensing, DXVX will remain responsible for leading R&D activities necessary for commercialization, including preclinical studies, Phase 1–3 clinical trials, and production. The partner company will be responsible for global regulatory approvals and sales. Other specific terms remain confidential by mutual agreement.

The mRNA-based cancer vaccine covered under this license agreement is part of DXVX’s proprietary pipeline and has demonstrated superior anticancer efficacy in preclinical animal studies compared to global competitors currently undergoing Phase 2b trials. DXVX has completed patent applications for the compound. In addition, the candidate utilizes DXVX’s proprietary long-term ambient storage mRNA vaccine platform technology, securing a technological edge over competitors.

The partnering U.S. biotech company possesses RNA-based drug development and diverse platform technologies. Following their first partnering meeting at the JP Morgan Healthcare Conference and Biotech Showcase this January, the partner recognized DXVX’s technological strengths, leading to the rapid conclusion of this agreement.

Kevin Kwon, CEO of DXVX, stated, “We are very pleased to sign our first global out-licensing agreement. We sincerely appreciate our partner’s recognition of our technological strength,” adding, “We believe this agreement will positively influence additional licensing discussions currently underway for other pipelines.”

Meanwhile, DXVX’s largest shareholder is Chong-Yoon Lim, Chairman of COREE and eldest son of the founder of Hanmi Pharmaceutical Group. In addition to the mRNA cancer vaccine, DXVX is developing several pipeline assets, including a long-term ambient storage mRNA vaccine platform, an oral anti-obesity therapeutic, and OVM-200, a peptide-based cancer vaccine, and other pipelines. The company is currently in licensing discussions with multiple domestic and international pharmaceutical and biotech companies.